Actively Recruiting
Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
Led by National Human Genome Research Institute (NHGRI) · Updated on 2026-04-28
5000
Participants Needed
5
Research Sites
N/A
Total Duration
On this page
Sponsors
N
National Human Genome Research Institute (NHGRI)
Lead Sponsor
U
University of Massachusetts, Worcester
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study is designed to explore the genetics and pathophysiology of diseases presenting with intermittent fever, including familial Mediterranean fever, TRAPS, hyper-IgD syndrome, and related diseases. The following individuals may be eligible for this natural history study: 1) patients with known or suspected familial Mediterranean fever, TRAPS, hyper-IgD syndrome or related disorders; 2) relatives of these patients; 3) healthy, normal volunteers 7 years of age or older. Patients will undergo a medical and family history, physical examination, blood and urine tests. Additional tests and procedures may include the following: 1. X-rays 2. Consultations with specialists 3. DNA sample collection (blood or saliva sample) for genetic studies. These might include studies of specific genes, or more complete sequencing of the genome. 4. Additional blood samples a maximum of 1 pint (450 ml) during a 6-week period for studies of white cell adhesion (stickiness) 5. Leukapheresis for collecting larger amounts of white cells for study. For this procedure, whole blood is collected through a needle in an arm vein. The blood flows through a machine that separates it into its components. The white cells are removed and the rest of the blood is returned to the body through another needle in the other arm. Patients may be followed approximately every 6 months to monitor symptoms, adjust medicine dosages, and undergo routine blood and urine tests. They will receive genetic counseling by the study team on the risk of having affected children and be advised of treatment options. Participating relatives will undergo a medical and family history, possibly with a review of medical records, physical examination, blood and urine tests. Additional procedures may include a 24-hour urine collection, X-rays, and consultations with medical specialists. A DNA sample (blood or saliva) will also be collected for genetic studies. Additional blood samples of no more than 550 mL during an 8-week period may be requested for studies of white cell adhesion (stickiness). Relatives who have familial Mediterranean fever, TRAPS, or hyper-IgD syndrome will receive the same follow-up and counseling as described for patients above. Normal volunteers and patients with gout will have a brief health interview and check of vital signs (blood pressure and pulse) and will provide a blood sample (up to 90 ml, or 6 tablespoons). Additional blood samples of no more than 1 pint over a 6-week period may be requested in the future.
CONDITIONS
Official Title
Familial Mediterranean Fever and Related Disorders: Genetics and Disease Characteristics
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Willingness to participate in study procedures, including providing a mail-in sample for genetic analysis
- At least 1 month old (for subjects with known or suspected autoinflammatory disease and their relatives)
- Medical history consistent with possible autoinflammatory disease (for subjects with known or suspected disease)
- Blood or marriage relation to an enrolled or about-to-be-enrolled individual with known or suspected autoinflammatory disease (for relatives)
- Likely to advance genetic or functional analysis of affected relative's condition (for relatives)
- Ability to understand and willingness to sign informed consent (for all participants)
- At least 1 year old and not pregnant (for healthy volunteers)
- Likely to advance functional analysis of autoinflammatory conditions under study (for healthy volunteers)
You will not qualify if you...
- Having a medical condition that would confuse the interpretation of the study results, as judged by the investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 5 locations
1
Childrens National Medical Center
Washington D.C., District of Columbia, United States, 20010
Completed
2
Johns Hopkins University
Baltimore, Maryland, United States, 21205
Completed
3
Walter Reed National Medical Center
Bethesda, Maryland, United States, 20301
Completed
4
National Institutes of Health Clinical Center
Bethesda, Maryland, United States, 20892
Actively Recruiting
5
University of Pittsburgh
Pittsburgh, Pennsylvania, United States, 15261
Not Yet Recruiting
Research Team
A
Amanda K Ombrello, M.D.
CONTACT
B
Benjamin D Solomon, M.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here